TABLE 10.
Model 1 |
Model 2 |
|||
Baseline cross-sectional effect | Effect on cognitive change | Baseline cross-sectional effect | Effect on cognitive change | |
Cosinor metrics | ||||
Amplitude | – | – | – | – |
Mesor | – | – | – | – |
Acrophase | −0.02 (−0.09, 0.04) | 0.003 (−0.01, 0.02) | −0.02 (−0.09, 0.04) | 0.004 (−0.01, 0.02) |
Non-parametric | ||||
RA | 0.02 (−0.04, 0.08) | 0.002 (−0.01, 0.02) | 0.01 (−0.06, 0.07) | 0.001 (−0.01, 0.02) |
IS | 0.05† (−0.01, 0.11) | −0.003 (−0.02, 0.01) | 0.05 (−0.02, 0.11) | −0.01 (−0.02, 0.01) |
IV | – | – | – | – |
L5 time | −0.004 (−0.06, 0.05) | †−0.01 (−0.02, 0.001) | 0.003 (−0.05, 0.06) | −0.01† (−0.02, 0.002) |
M10 time | −0.01 (−0.07, 0.05) | 0.01 (−0.01, 0.02) | −0.01 (−0.07, 0.05) | 0.01 (−0.01, 0.02) |
– = significant interaction, main effect not reported (see tables below). Model 1 adjusted for baseline age, sex, race, years of education, time, baseline age*time, sex*time, race*time, and years of education*time. Model 2 adjusted for Model 1 covariates, in addition to baseline BMI, sleep medication use, APOE e4 status, depression symptoms (minus the sleep item), cardiovascular disease risk, smoking status, BMI*time, cardiovascular disease risk*time, smoking status*time, sleep medication*time, APOE e4 status*time, and depression symptoms (minus the sleep item)*time. †p < 0.10.